Entropy Technologies »

Nektar Therapeutics shares owned by Entropy Technologies

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $330k 4.6k 71.95

More positions owned by Entropy Technologies

Cheniere Energy Ord Com New (LNG)
Boston Scientific Corporation (BSX)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Colgate-Palmolive Company (CL)
FedEx Corporation (FDX)
Chevron Corporation (CVX)
Occidental Petroleum Corporation (OXY)
Lockheed Martin Corporation (LMT)
Medtronic Ord SHS (MDT)
PG&E Corporation (PCG)
Palantir Technologies Cl A Ord Cl A (PLTR)
Blackrock (BLK)
Trane Technologies Ord SHS (TT)
Mastercard Cl A Ord Cl A (MA)

View all positions for Entropy Technologies

Top funds holding Nektar Therapeutics

FMR
BVF
Two Seas Capital
Vanguard Capital Management
Two Sigma Investments
Susquehanna International
Prosight Management
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics